Regulatory & Legal

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

Greece signs a landmark deal with Chevron and HELLENiQ for deep-sea hydrocarbon exploration, seeking energy independence amid high environmental stakes.

After a costly regulatory exit, crypto giant Nexo plans a 2026 U.S. return, partnering with Bakkt in a bid to redefine compliant digital finance.

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

A new partnership combines fitness and philanthropy, leveraging a national anti-bullying movement to support youth programs across Canada. Here's how you can join.

New drill results confirm a shallow, rich copper-gold zone at La Verde, boosting the economics of the Costa Fuego project with a potential starter pit.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

With a key gas deal signed, construction begins on the world's largest ultra-low carbon methanol plant in Sinaloa, a $3.3B bet on sustainable fuels.

Amid unprecedented supply chain chaos, Westrock Coffee met its 100% responsible sourcing goal. Here's how they did it and what it means for the industry.

With no approved nonsurgical options for plantar fibromatosis, Keenova's new study and late-stage trial offer a significant glimmer of hope for sufferers.

After a brutal 2024 and a massive strategy shift, all eyes are on Stellantis's 2025 earnings. Will the numbers justify its painful pivot away from EVs?

A new platform debuts, offering access to 30,000+ global assets from a single account, aiming to dismantle barriers for long-term retail investors.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

The USB-C market is set to quadruple, driven by global regulations and advanced tech. But what are the hidden costs and who is winning the race to dominate?

Indian startup DUSQ lands ₹24 crore to challenge global sleep-tech giants with a novel platform that promises to restore sleep, not just score it.

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

With $100M from its new IPO, XFLH Capital joins a resurgent SPAC market. But can its Asia-focused strategy overcome a history of investor risk?